Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-energy differential target multiplexed SCS derivative reduces pain and improves quality of life through 12 months in patients with chronic back and/or leg pain.
Peacock J, Provenzano D, Fishman M, Amirdelfan K, Bromberg T, Schmidt T, White T, Grewal P, Justiz R, Calodney A, El-Naggar A, Shah B, Esposito M, Gatzinsky K, Kallewaard JW, Poree L, Cleland A, Rice C, Theis E, Noel K, LaRue M. Peacock J, et al. Among authors: el naggar a. Pain Pract. 2025 Jan;25(1):e13407. doi: 10.1111/papr.13407. Epub 2024 Sep 11. Pain Pract. 2025. PMID: 39258956 Free PMC article.
Differential Target Multiplexed Spinal Cord Stimulation for the Treatment of Chronic Intractable Upper Limb Pain: 12-Month Results From a Prospective, Multicenter Study.
White T, Justiz R, Fishman M, Schultz D, Calodney A, Cordner H, Almonte W, Millet Y, Wu K, Gekht G, Will A, Kim P, Bundschu R, Sirianni J, El-Naggar A, Gupta M, Park W, Cedeño DL, Vallejo R. White T, et al. Neuromodulation. 2024 Dec;27(8):1441-1448. doi: 10.1016/j.neurom.2024.06.497. Epub 2024 Jul 25. Neuromodulation. 2024. PMID: 39046394 Free article.
Twelve-month results from a randomized controlled trial comparing differential target multiplexed spinal cord stimulation and conventional spinal cord stimulation in subjects with chronic refractory axial low back pain not eligible for spine surgery.
White T, Justiz R, Almonte W, Micovic V, Shah B, Anderson E, Kapural L, Cordner H, El-Naggar A, Fishman M, Eshraghi Y, Kim P, Abd-Elsayed A, Chakravarthy K, Millet Y, Sanapati M, Harrison N, Goff B, Gupta M, Grewal P, Wilkinson M, Bundschu R, Will A, Satija P, Li S, Dulebohn S, Broadnax J, Gekht G, Wu K, Falowski S, Park W, Cedeno DL, Vallejo R. White T, et al. Among authors: el naggar a. N Am Spine Soc J. 2024 Jul 17;19:100528. doi: 10.1016/j.xnsj.2024.100528. eCollection 2024 Sep. N Am Spine Soc J. 2024. PMID: 39229594 Free PMC article.
Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms.
Serrano AG, Rocha P, Freitas Lima C, Stewart A, Zhang B, Diao L, Fujimoto J, Cardnell RJ, Lu W, Khan K, Sable B, Ellison AR, Wistuba II, Concannon KF, Halperin DM, Bogdan C, Sircar K, Zhang M, Cargill K, Wang Q, Aparicio A, Lazar A, Hernandez S, Estrella J, Ramalingam P, El-Naggar A, Kalhor N, Gay CM, Byers LA, Solis Soto LM. Serrano AG, et al. Among authors: el naggar a. NPJ Precis Oncol. 2024 Nov 19;8(1):268. doi: 10.1038/s41698-024-00739-y. NPJ Precis Oncol. 2024. PMID: 39558076 Free PMC article.
Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma.
Contrera KJ, Ferrarotto R, Gunn B, Su SY, Kies MS, Glisson BS, Garden AS, Roberts D, Hanba C, Hoff CO, El-Naggar A, Williams MD, Raza SM, DeMonte F, Chen MM, Chambers MS, Hanna EY. Contrera KJ, et al. Among authors: el naggar a. Clin Cancer Res. 2024 Nov 12. doi: 10.1158/1078-0432.CCR-24-1416. Online ahead of print. Clin Cancer Res. 2024. PMID: 39531535
1,101 results